Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog that binds to GHRH receptors in the pituitary gland, stimulating the release of endogenous growth hormone. This leads to increased lipolysis, enhanced fat metabolism, and specific reduction in visceral adipose tissue, particularly effective in treating HIV-associated lipodystrophy. The FDA-approved mechanism targets visceral fat through growth hormone-mediated metabolic pathways.

What it’s Used for

Tirzepatide is a dual GIP/GLP-1 receptor agonist that revolutionizes treatment for both type 2 diabetes and weight management. It’s the first medication to target both incretin pathways, providing superior results compared to single-receptor drugs.

Weight Loss – Glucose control – Cardiovascular Protection